Paxman are committed to an ambitious research and development program, allowing us to continuously refine the efficacy and ease of use of the Paxman Scalp Cooling System and cap.
A significant share of the Paxman’s research and development program is conducted in collaboration with a multidisciplinary research team at the University of Huddersfield. The research team have expert knowledge in relevant areas, including biological and chemical research on hair follicles and product development.
In February 2019, the 5 year collaboration agreement was formalized between Paxman and the University of Huddersfield as the Paxman Research & Innovation Centre, the world’s first multidisciplinary research centre focused on scalp cooling.
The centre will focus on biological hair follicle research as well as developing innovative scalp cooling-related treatments and individual 3D-printed cooling caps.
The £1million investment in cash, staffing and other resources during the first 5 years will be jointly funded by PAXMAN and the University of Huddersfield.
Initially, the research team will focus on three key projects:
Biological research with human hair follicles cultivates in a laboratory environment
- By studying human hair follicles under various conditions, researchers can gain significant in-depth knowledge on how their different biological and chemical processes are affected by chemotherapy as well as scalp cooling. This research is used to optimise existing and future generations of the Paxman Scalp Cooling System.
Development of an ecosystem for 3D-printed individual cooling caps.
- Individually designed cooling caps tailored to each patient’s scalp could provide increased efficacy with the use of the current Paxman Scalp Cooling System. The individually cooling caps are planned to be manufactured in recyclable and environmentally friendly materials.
Development of a topically applied product that enhances the effect of scalp cooling
- The research team has already proven that the lotion-like product can contribute to a significantly enhanced effect in initial in vitro tests. As the product is applied directly to the patient’s head, it can be used with the current generation of the Paxman Scalp Cooling System. this is expected to reduce the time to a potential market launch considerably.